المؤلفون: Davis EJ; Department of Internal Medicine, Division of Hematology-Oncology., Griffith KA; Department of Biostatistics, University of Michigan, Ann Arbor, MI., Kim EJ; Department of Internal Medicine, Division of Hematology-Oncology., Ruch JM; Department of Internal Medicine, Division of Hematology-Oncology., McDonnell KJ; Department of Internal Medicine, Division of Hematology-Oncology., Zalupski MM; Department of Internal Medicine, Division of Hematology-Oncology.

المصدر: American journal of clinical oncology [Am J Clin Oncol] 2018 Feb; Vol. 41 (2), pp. 128-132.

نوع المنشور: Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8207754 Publication Model: Print Cited Medium: Internet ISSN: 1537-453X (Electronic) Linking ISSN: 02773732 NLM ISO Abbreviation: Am J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Biliary Tract Neoplasms/*drug therapy , Biliary Tract Neoplasms/*mortality , Pancreatic Neoplasms/*drug therapy , Pancreatic Neoplasms/*mortality, Adenocarcinoma/drug therapy ; Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Biliary Tract Neoplasms/pathology ; Cisplatin/administration & dosage ; Cisplatin/adverse effects ; Deoxycytidine/administration & dosage ; Deoxycytidine/adverse effects ; Deoxycytidine/analogs & derivatives ; Disease-Free Survival ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Female ; Fluorouracil/administration & dosage ; Humans ; Infusions, Intravenous ; Male ; Middle Aged ; Neoplasm Invasiveness/pathology ; Neoplasm Metastasis ; Neoplasm Staging ; Pancreatic Neoplasms/pathology ; Patient Selection ; Prognosis ; Risk Assessment ; Survival Analysis ; Treatment Outcome ; Gemcitabine